| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0264-410X(94)90124-4 |
| P698 | PubMed publication ID | 8023554 |
| P2093 | author name string | Savage PK | |
| Vakharia VN | |||
| Goodwin MA | |||
| Lütticken D | |||
| Snyder DB | |||
| Edwards GH | |||
| Mengel-Whereat SA | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Infectious bursal disease virus | Q707615 |
| P304 | page(s) | 452-456 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins | |
| P478 | volume | 12 |
| Q37492711 | A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. |
| Q37382392 | Acute infectious bursal disease in poultry: a review |
| Q39028830 | Advances in vaccine research against economically important viral diseases of food animals: Infectious bursal disease virus |
| Q33729299 | Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens |
| Q39539731 | Characteristics of bursal T lymphocytes induced by infectious bursal disease virus |
| Q39162472 | Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses |
| Q42058392 | Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography |
| Q45399855 | DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens |
| Q79224766 | Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens |
| Q43962749 | Development of a vaccine for immunization against classical as well as variant strains of infectious bursal disease virus using reverse genetics |
| Q35622386 | Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus |
| Q45567592 | Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2. |
| Q39578879 | Generation of a mutant infectious bursal disease virus that does not cause bursal lesions |
| Q33862814 | Infectious bursal disease virus of chickens: pathogenesis and immunosuppression |
| Q61805341 | Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and V |
| Q41929214 | Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens |
| Q45403033 | Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens |
| Q92223158 | Plant-based vaccine candidate against Infectious bursal disease: An alternative to inactivated vaccines for breeder hens |
| Q45730461 | Protective immunity against infectious bursal disease virus in chickens in the absence of virus-specific antibodies |
| Q34424968 | Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit |
| Q35592766 | Research on infectious bursal disease--the past, the present and the future |
| Q42047559 | Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. |
| Q45386977 | Transfer of antibodies elicited by baculovirus-derived VP2 of a very virulent bursal disease virus strain to progeny of commercial breeder chickens |
| Q42266894 | Transient expression of VP2 in Nicotiana benthamiana and its use as a plant-based vaccine against infectious bursal disease virus. |
| Q45711213 | Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection |
| Q36601830 | Vaccines for viral and parasitic diseases produced with baculovirus vectors |
Search more.